Linzagolix for treating symptoms of endometriosis (TA1067)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 4 June 2025
Relugolix–estradiol–norethisterone for treating symptoms of endometriosis (TA1057)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 16 April 2025
Endometriosis: diagnosis and management (NG73)Product type:GuidanceProgramme:NICE guidelineLast updated: 11 November 2024Published: 6 September 2017
Linzagolix for treating moderate to severe symptoms of uterine fibroids (TA996)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 14 August 2024
Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids (TA832)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 19 October 2022
Sonata system for diagnostic imaging and treatment of symptomatic uterine fibroids (MIB255)Product type:AdviceProgramme:Medtech innovation briefingPublished: 30 March 2021
Technologies for the rapid diagnosis of endometriosisStatus:In developmentProgramme:Health technology evaluationExpected publication date: 8 October 2026
Ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroidsStatus:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC
Transvaginal Ultrasound-Guided Radiofrequency Ablation (RFA) for Uterine FibroidsStatus:Awaiting developmentProgramme:HealthTech guidanceExpected publication date: TBC
Thermal Probe Ablation for abdominal wall endometriosisStatus:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC